Meeting Details
The 21st Annual General Meeting (AGM) of Asarfi Hospital Limited was held on Friday, 18th September 2026. The meeting commenced at 12:00 noon and concluded at 2:00 PM at the Registered Office of the Company: 4th Floor, Asarfi Hospital, Baramuri, Bishunpur Polytechnic, Dhanbad, Jharkhand – 828130.
Attendance
- 16 Members and 6 Proxy/Authorized Representatives were present at the Meeting
- Remote e-voting facility was provided through NSDL, commencing on 15th September 2026 at 10:00 A.M. and ending on 17th September 2026 at 05:00 P.M.
- CS Sourav Mall (Membership No. A67274) was appointed as Scrutinizer to scrutinize the remote e-voting process and voting at the AGM
Directors and Key Managerial Personnel Present:
- Udai Pratap Singh, Managing Director (Present)
- Madhuri Singh, Executive Director (Present)
- Dr. Sukanti Kumar Das, Non-Executive Director and Chairman (Present)
- Gopal Singh, Director (Present)
- Rajkumari Sharma, Independent Director (Present)
- Harendra Singh, Chief Financial Officer (Present)
- Sudipa Singh, Company Secretary & Compliance Officer (Present)
Directors Absent:
- Amit Kumar Barnwal, Independent Director (Absent)
Business Transacted
The following items of business from the Notice convening the 21st AGM were considered and approved:
1. Ordinary Business: To receive, consider and adopt the Audited Standalone Financial Statements and Audited Consolidated Financial Statements of the Company for the financial year ended 31st March 2026, together with the Reports of the Board of Directors and Auditors thereon. (Ordinary Resolution)
2. Ordinary Business: To appoint Mr. Gopal Singh (DIN: 01608342) as Director, who retires by rotation and being eligible offers himself for re-appointment. (Ordinary Resolution) - APPROVED
3. Special Business: Migration From BSE SME Platform To BSE Main Board And Listing of Equity Shares On National Stock Exchange of India Limited - APPROVED
Proceedings
Dr. Sukanti Kumar Das chaired the meeting as Chairman. The Chairman delivered his speech and invited the Chief Financial Officer to state the future plans and growth projections of the Company. The Statutory Registers and other documents were available for inspection during the meeting. The Chairman invited comments/queries from Members present, and management responded to all queries raised. All resolutions were transacted through the prescribed voting process.
The meeting was conducted in accordance with the Companies Act, 2013 and the Rules framed thereunder.